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MolecularABSTRACT
Objective: To assess the anticancer activity of eight cyanobacterial hydrophilic extracts
on Ehrlich ascites carcinoma cell line.
Methods: The cyanobacterial strains used in the investigation were collected from
diverse habitats in Egypt. The initial cytotoxicity test of cyanobacterial hydrophilic ex-
tracts was carried out by MTT assay. The in vitro anticancer activity of the four most
active extracts was performed on MCF-7 cells using sulforhodamine B assay. Morpho-
logical and molecular techniques were used to characterise identity of the isolate from
which the most potent cytotoxic extract was obtained.
Results: Extracts from four cyanobacterial strains had higher cytotoxic activities scoring
76.68%, 77.70%, 76.70% and 74.45%, respectively. A considerable anticancer effect was
only detected when the concentrated extracts were used. One cyanobacterial extract gave
the highest anticancer activity on human breast adenocarcinoma cell line (57.6% of in-
hibition) as compared to control. The isolate was best-matched to Cyanothece sp. with
sequence resemblance 98% to Cyanothece sp. strain PCC7564 and the phylogenetic
analysis conﬁrmed its close identity to the Cyanothece genus.
Conclusions: This is the ﬁrst study to report the anticancer effect of aqueous extracts
derived from the unicellular Cyanothece sp. from Egypt and its potential as a plausible
candidate for future mass biotechnological applications.1. Introduction
Cyanobacteria are reported to be a promising source of a
wide range of rather unique yet underexplored bioactive me-
tabolites that requires further exploration and gene mining [1,2].
Several studies showed that the bioactive compounds derived
from cyanobacteria had anticancer effect [3,4]. In Egypt, local
cyanobacterial strains have proved to be a proliﬁc source of
antimicrobial agents [5,6]. However, in an effort to further
explore the anticancer activity of local strains, this study was
conducted to investigate the anticancer activity of their
extracts. In addition, the identity of one local cyanobacterial
strain that gave us cytotoxic activity was investigated to
accurately describe its taxonomic position in order to reveal
some of its physiological aspects. Overall, we aim to highlightthe potential of using local underreported and unexploited
cyanobacteria that are easily cultivated and extracted as a
promising source of anticancer agents.
2. Materials and methods
2.1. Cyanobacterial cultures
The cyanobacterial cultures used are all collected from
different locatities in Egypt including Wadi El Rayan, Oyoun
Mousa, the Nile and Wadi El Natroun in 2013 and 2014. There
were identiﬁed and kept at Helwan Culture Collection. Never-
theless, the identity of the isolate understudy is yet to be
investigated. The isolate under study is oval or cylindrical uni-
cellular cyanobacterium which was kept as a clonal culture
pending identiﬁcation. All cultures were kept in modiﬁed BG-11
medium [7] at room temperature. Cyanobacterial fresh biomass
was harvested by centrifugation at 6000 r/min for 10 min,
supernatant was decanted and fresh weight was determined.
Ten milliliter of distilled water was added to the fresh biomass
and the cells were sonicated using an ultrasound sonicator at aen access article under the CC BY-NC-ND
Table 1
Percent cell inhibition of eight cyanobacterial hydrophilic extracts on
EAC cell line.
Isolate
number
Cyanobacterial
isolates
% Cell inhibition
on EAC
1 L. badia 76.68
2 Oscillatoria limentica 71.46
3 Phormidium uncinatum 69.30
4 (Isolate under study) 77.70
5 P. pristleyi 74.45
6 P. terebans 76.70
7 Cyanobacterium notatum 66.26
8 Synechocystis salina 74.20
L. badia: Leptolyngya badia; P. pristleyi: Phormidium pristleyi;
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until all cells were broken. The homogenized cell lysate was
centrifuged at 6000 r/min for 20 min to obtain cell-free super-
natant which represents the cyanobacterial hydrophilic extract.
The supernatant was collected and used for cytotoxicity test.
2.2. Cell lines
Ehrlich ascites carcinoma (EAC) cell line was obtained from
the National Cancer Institute, Cairo University. The cells were
maintained in the ascitic form in vivo in Swiss albino mice by
means of sequential intraperitoneal transplantation of
2 × 106 cells/mouse after every 10 days. Human breast adeno-
carcinoma cell line (MCF-7) was obtained from the American
Type Culture Collection (ATCC, Minnesota, USA). The tumor
cell line was maintained at the National Cancer Institute, Cairo,
Egypt, by serial sub-culturing.
2.3. Initial cytotoxicity test of cyanobacterial
hydrophilic extracts by MTT method
The anticancer activity was judged by MTT assay [8]. Brieﬂy,
0.2 mL of freshly prepared EAC cell suspension was seeded in
each well of 24-well plates. Cells were incubated with 0.2 mL
from the eight cyanobacterial hydrophilic extracts at a concen-
tration of 1 mg/mL for 24 h at 37 C, 5% CO2 with 98% relative
humidity. A fresh medium was used containing 0.5 mg/mL of
MTT for 2 h. The supernatant was aspirated and MTT formazan
crystals were dissolved in 0.5 mL of a mixture of iso-propanol
and 0.1 mol/L HCl. Absorbance was measured at 560 nm by
using a spectrophotometer. The effect of extract on the prolif-
eration of EAC cells was expressed as the percent of cell
viability, using the following formula:
% of cell inhibitionðdeathÞ= 100− ðAbsorbance of
sample=Absorbance of control × 100Þ
2.4. Anticancer activity of the four selected
cyanobacterial hydrophilic extracts by sulforhodamine
B (SRB) method
The in vitro anticancer activity of the most active extracts
was performed on MCF-7 cells using SRB assay as it is a sen-
sitive method for evaluating cytotoxic activity [9]. Cells were
seeded in 96-well microtiter plates at initial concentration of
3 × 103 cell/well in a 150 mL fresh medium and left for one
day to attach to the plates in CO2 incubator at 37 C. Later,
test extracts were added to wells in a broad concentration
range (0, 250, 500, 750 and 1000 mg/mL) and incubated for
48 h. Fixation was performed using 50 mL of 50%
trichloroacetic acid at 4 C for 1 h. The plates were washed
with distilled water using automatic washer (Tescan,
Germany) and stained with 50 mL 0.4% SRB dissolved in 1%
acetic acid for 30 min at room temperature. The excess of dye
was removed by washing 4 times with 1% acetic acid. The
dye was solubilized with 100 mL of 10 mmol/L Tris-base (pH
10.4) and optical density of each well was measured spectro-
photometrically at 570 nm with an ELISA microplate reader
(Sunrise Tecan reader, Germany). Percent of cell death was
calculated using following formula:% of cell inhibitionðdeathÞ = 100− ðAbsorbance of
sample=Absorbance of control × 100Þ
2.5. Cyanobacterial morphological and molecular
characterization
The cyanobacterial cells were unicellular, oval with cylin-
drical appearance when dividing with no common gelatinous
sheath. Cells possessed granular appearance. The DNA was
extracted using Promega DNA extraction kit. The large 23S
subunit rRNA gene was used as a taxonomic marker [10]. The
puriﬁed genomic DNA was used as a template for
ampliﬁcation of partial 23S rDNA using the primer pair
p23SrV_f1: GGA CAG AAA GAC CCT ATG AA and
p23SrV_r1: TCA GCC TGT TAT CCC TAG AG [10]. The
partial 23S rDNA sequence was deposited in the GenBank
database under the accession number KM392420.
3. Results
3.1. Initial cytotoxicity test of cyanobacterial
hydrophilic extracts using MTT method
The cyanobacterial hydrophilic extracts of isolates number 1,
4, 5 and 6 showed higher cytotoxic activities in this MTT assay
(Table 1). The maximal inhibition of cell growth was 76.68%,
77.70%, 74.45% and 76.70% respectively and obtained with
1 mg/mL of the extracts. Whereas the other isolates extracts
showed lower inhibitions which are 71.46%, 69.30%, 66.26%
and 74.20% for isolates number 2, 3, 7 and 8, respectively.
3.2. Anticancer activity of the potent extracts by SRB
method
The cytotoxic activity of the most active four hydrophilic
extracts on the growth of the human breast cancer MCF-7 cell
line was presented in Table 2. Anticancer activity was analyzed
after 48 h. The undiluted concentration used in the study was
1000 mg/mL. When the undiluted concentrated hydrophilic ex-
tracts were used, different inhibition percentages for different
extracts were obtained. The highest inhibition percentage of
which was 57.6% for the isolate understudy, whereas the extract
from L. badia isolate displayed weak inhibition of only 12.1%.
Interestingly, the other remaining two extracts scored similarP. terebans: Plectonema terebans.
Table 2
Percent cell inhibition of the most active four cyanobacterial hydrophilic
extracts on MCF-7 cell line. %.
Concentration
(mg/mL)
Isolate under
study
L. badia P. terebans P. pristleyi
0 0.0 0.0 0.0 0.0
250 15.3 12.6 18.4 0.0
500 24.5 21.2 20.8 7.6
750 50.6 17.0 30.8 34.6
1000 57.6 12.1 46.7 46.7
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different dilutions made to the hydrophilic extract did not show
any anticancer activity indicating the importance of the appli-
cation of the concentrated extract directly.
3.3. Molecular analysis
The molecular analysis revealed the unicellular cyanobac-
teria to be Cyanothece isolate with a similarity 98% to the
closest-related isolate Cyanothece sp. PCC78801. Statistical
signiﬁcance E was 0.0 indicating the null possibility of random
similarity. The other closely-related isolates were other Cya-
nothece and unicellular strains with similarity 93% or less.
Sequences in the FASTA format from representatives from
different cyanobacterial sections were downloaded and aligned
to allow phylogenetic tree reconstruction and sequence of
partial 23S rDNA from Cryptomonas curvata (C. curvata), a
eukaryotic microalgae, was used as an out-group taxon to root
the tree.
3.4. Phylogenetic inference and tree reconstruction
The evolutionary history was inferred using the maximum
parsimony method [11]. The maximum parsimony tree was
obtained using the close-neighbor-interchange algorithm [12].
There were 336 positions in the ﬁnal dataset, out of which
180 were parsimony informative sites. Phylogenetic analyses
were conducted in molecular evolutionary genetics analysis
software version 4.0 [13]. Bootstrap support values greater than
50% were reported (Figure 1). The eukaryotic alga C. curvata
was used as an out-group taxon.Figure 1. Phylogenetic bootstrapped tree based on maximum parsimony
method showing evolutionary relationships of other related taxa to our
isolate.
We arbitrarily designated our isolate as Cyanothece Helwan (accession
number KM392420). Other taxa with accession numbers included:
Arthrospira sp. strain PCC8005 (FO818640); Arthrospira platensis
(JN831263); Cyanothece sp. PCC78801 (NR_076616); Acaryochloris
marina MBIC11017 strain MB (AY518279); C. curvata strain CNUCRY
19 (KF907414); Uncultured organism clone C6.81 (EU342081) and Spir-
ulina maxima UTEX LB2342 (JN831262).4. Discussion
Cancer is a condition in which cells divide uncontrollably
and may spread to other tissues unlike normal cells which divide
in a controlled manner [14]. Programmed cell death (apoptosis) is
important to prevent cancer but cancerous cells for several
reasons cannot enter apoptotic phase [15]. Efforts are focused
on making cancer cells enter apoptotic stage. In that context, it
is reported that microalgal extracts can be effective in
inducing apoptosis in cancer cells [15]. In that regard,
cyanobacteria are considered as a promising source of
anticancer agents regardless of their geographical origin,
genera and climate [16]. They may induce cancerous cell death
through causing the condensation of chromatin and the
fragmentation of the nucleus in addition to and release of
apoptotic bodies [17]. We screened some of the local strains
for anticancer agents of which Cyanothece sp. gave the
highest anticancer activities. The identity of this unicellular
cyanobacterium was conﬁrmed by both molecular and
phylogenetic analyses and was grouped with other Cyanothece
strain in one subclade with 100% bootsrap values. This
unicellular cyanobacterium is unique in terms of physiological
activity. It is capable of alternating photosynthesis during the
day with nitrogen ﬁxation during the night thereby
contributing to both nitrogen and carbon cycle [18]. This
regulation is important for photosynthesis generating oxygen
which can cause irreversible inhibition of the nitrogenase
enzyme responsible for nitrogen ﬁxation [1]. The regulation of
those two rather contradicting processes is therefore enigmatic.
Genome sequencing studies revealed the adaptability of this
organism's genome to different environmental conditions [18].
The use of combined molecular and morphological approach
for the description of prokaryotes is necessary due to lack of
morphological diagnostic phenotypic characters especially in
unicellular prokaryotes [6]. Interestingly, Cyanothece sp. was
reported to possess sulphated polysaccharides that are capable
of inhibiting the adhesion of pathogenic bacteria Helicobacter
pylori to gastric epithelial cells [19]. Interestingly, extracts
derived from Cyanothece sp. strain had high anticancer impact
on T-lymphoma cells but not against myelogenic leukemia
cells [16]. In that context, unicellular cyanobacteria are reported
to be a promising source of anticancer compounds [20].
Moreover, it was reported that cyanobacterial extracts contain
long-lasting effective apoptotic compounds [16]. Their
apoptotic effects may be attributed to causing the cancerous
cells to undergo cell cycle arrest, mitochondrial dysfunctions
and drastic changes in certain enzymes and proteins levels as
well as changing membrane sodium dynamics [21–24]. In
addition some of the known cyanobacterial toxins were
suggested to have anticancer effects such as the hepatotoxin
microcystins that cause hepatic cellular damage and induces
reactive oxygen species [22,25]. These toxins are being
transported by organic anion transporting polypeptides [22]. As
cancer cells are already vulnerable to reactive oxygen species,
microcystins and their analogues can selectively kill cancer
cells that express certain organic anion transporting
polypeptides without adversely affecting normal cells [22,26]. In
addition, some compounds with anticancer activity from
cyanobacteria were identiﬁed including synthadotin [27],
cryptophycin 1 [28] and curacin [24]. Recently, the
cyanobacteria isolated from extreme environments are proved
to be potent source of anticancer drugs especially against new
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need for extensive exploration of those isolates because of
their unique bioactive metabolites [29]. In line with that,
aqueous extracts from several ﬁlamentous cyanobacteria from
Egypt were proved to be very effective against cancer cell
lines [30]. In that regard, the current study represents the ﬁrst
report to show the anticancer effect of aqueous extracts
derived from the unicellular Cyanothece sp. from Egypt. It is
noteworthy that more attention is wanted to shed some light
on microﬂora isolated from that subtropical part of the world
whose biological wealth is largely underexplored let alone
exploited despite their unique metabolic products [5]. The
promising results together with the simple and cost-effective
culturing and extraction technique make this isolate quite plau-
sible candidate for future mass biotechnological applications.
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